{"id":25161,"date":"2023-09-15T11:55:00","date_gmt":"2023-09-15T16:55:00","guid":{"rendered":"https:\/\/myeloma.ca\/?p=25161"},"modified":"2025-08-19T08:28:10","modified_gmt":"2025-08-19T13:28:10","slug":"selinexor-maintenant-finance-en-saskatchewan","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/09\/15\/selinexor-maintenant-finance-en-saskatchewan\/","title":{"rendered":"Selinexor maintenant financ\u00e9 en Saskatchewan!"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Nous sommes heureux d&rsquo;informer notre communaut\u00e9 que depuis le 1er septembre,<strong> XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur<\/strong>, est maintenant rembours\u00e9 en Saskatchewan.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici : <a href=\"\" target=\"_blank\" rel=\"noopener\" title=\"\">Drug Formulary (saskcancer.ca).<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous sommes heureux d&rsquo;informer notre communaut\u00e9 que depuis le 1er septembre, XPOVIO\u00ae (selinexor) en association avec le bort\u00e9zomib et la dexam\u00e9thasone (XVd) pour le traitement des patients adultes atteints de my\u00e9lome multiple qui ont re\u00e7u au moins un traitement ant\u00e9rieur, est maintenant rembours\u00e9 en Saskatchewan. Plus de d\u00e9tails sur les crit\u00e8res de remboursement ici : [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53,6,58],"tags":[],"class_list":["post-25161","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-non-classifiee","category-nouvelles-de-myelome-canada"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/25161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=25161"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/25161\/revisions"}],"predecessor-version":[{"id":25162,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/25161\/revisions\/25162"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=25161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=25161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=25161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}